The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Pseudomonas aeruginosa pyocyanin and 1-hydroxyphenazine inhibit fungal growth.
Open accessAbstract
AIM: To examine strains of Pseudomonas aeruginosa for specific antifungal factors. METHODS: Two clinical strains of P aeruginosa with strong in vitro inhibition (by cross streak assay) of Candida albicans and Aspergillus fumigatus were examined. Both strains were isolated from sputum--one from a patient with cystic fibrosis and one from a patient with bronchiectasis. Bacterial extracts were fractionated by high performance liquid chromatography and examined by ultraviolet absorbance and mass spectroscopy. Antifungal activity against C albicans and A fumigatus was determined in a well plate assay. RESULTS: Pyocyanin was the major antifungal agent of P aeruginosa; 1-hydroxy-phenazine also possessed activity. Pyocyanin MICs for C albicans and A fumigatus were > 64 micrograms/ml. These phenazines were active against nine other yeast species pathogenic for man. Preliminary experiments also suggested possible inhibition of yeast mycelial transformation in C albicans by pyocyanin. CONCLUSIONS: There may be a role for pyocyanin and 1-hydroxyphenazine in the prevention of pulmonary candidiasis in patients colonised by P aeruginosa.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wilson, R., Sykes, D. A., Watson, D., Rutman, A., Taylor, G. W., & Cole, P. J. (1988) · Infection and Immunity · doi:10.1128/iai.56.9.2515-2517.1988 · Cited by 374
Self-citationWilson, R., Pitt, T., Taylor, G., Watson, D., MacDermot, J., Sykes, D., Roberts, D., & Cole, P. (1987) · Journal of Clinical Investigation · doi:10.1172/jci112787 · Cited by 262
Self-citationMechanisms of action of Pseudomonas aeruginosa pyocyanin on human ciliary beat in vitro
Kanthakumar, K., Taylor, G. W., Tsang, K. W., Cundell, D. R., Rutman, A., Smith, S., Jeffery, P. K., COLE, P. J., & Wilson, R. (1993) · Infection and Immunity · doi:10.1128/iai.61.7.2848-2853.1993 · Cited by 114
Self-citationSuppression of fungal growth exhibited by Pseudomonas aeruginosa
Kerr, J. R. (1994) · Journal of Clinical Microbiology · doi:10.1128/jcm.32.2.525-527.1994 · Cited by 105
Self-citationKerr, J. (1994) · Journal of Infection · doi:10.1016/s0163-4453(94)91943-7 · Cited by 65
Self-citationMycoflora in cystic fibrosis: Some ecologic aspects of pseudomonas aeruginosa and Candida albicans
Hughes, W. T., & Kim, H. K. (1973) · Mycopathologia · doi:10.1007/bf02053377 · Cited by 43
Cited by
Skin microbiota: a source of disease or defence?
Cogen, A. L., Nizet, V., & Gallo, R. L. (2008) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2008.08437.x · Cited by 952
Frey-Klett, P., Burlinson, P., Deveau, A., Barret, M., Tarkka, M., & Sarniguet, A. (2011) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00020-11 · Cited by 913
Microbial fuel cells: An overview of current technology
Slate, A. J., Whitehead, K. A., Brownson, D. A. C., & Banks, C. E. (2019) · Renewable and Sustainable Energy Reviews · doi:10.1016/j.rser.2018.09.044 · Cited by 725
Polymicrobial Interactions: Impact on Pathogenesis and Human Disease
Peters, B. M., Jabra-Rizk, M. A., O'May, G. A., Costerton, J. W., & Shirtliff, M. E. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.00013-11 · Cited by 712
The role of pyocyanin in Pseudomonas aeruginosa infection
Lau, G. W., Hassett, D. J., Ran, H., & Kong, F. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.10.002 · Cited by 688
Medically important bacterial-fungal interactions
Peleg, A. Y., Hogan, D. A., & Mylonakis, E. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2313 · Cited by 619
Phenazine Compounds in Fluorescent Pseudomonas Spp. Biosynthesis and Regulation
Mavrodi, D. V., Blankenfeldt, W., & Thomashow, L. S. (2006) · Annual Review of Phytopathology · doi:10.1146/annurev.phyto.44.013106.145710 · Cited by 572
Farnesol, a common sesquiterpene, inhibits PQS production in Pseudomonas aeruginosa
Cugini, C., Calfee, M. W., Farrow, J. M., Morales, D. K., Pesci, E. C., & Hogan, D. A. (2007) · Molecular Microbiology · doi:10.1111/j.1365-2958.2007.05840.x · Cited by 332
Price-Whelan, A., Dietrich, L. E. P., & Newman, D. K. (2007) · Journal of Bacteriology · doi:10.1128/jb.00505-07 · Cited by 315
Importance of Candida–bacterial polymicrobial biofilms in disease
Harriott, M. M., & Noverr, M. C. (2011) · Trends in Microbiology · doi:10.1016/j.tim.2011.07.004 · Cited by 313
Pihet, M., Carrere, J., Cimon, B., Chabasse, D., Delhaes, L., Symoens, F., Bouchara, J.-P., Pihet, M., Carrere, J., Cimon, B., et al. (2009) · Medical Mycology · doi:10.1080/13693780802609604 · Cited by 303
Fungal—bacterial interactions: a mixed bag of mingling microbes
Wargo, M. J., & Hogan, D. A. (2006) · Current Opinion in Microbiology · doi:10.1016/j.mib.2006.06.001 · Cited by 286
Azoulay, E., Timsit, J.-F., Tafflet, M., de Lassence, A., Darmon, M., Zahar, J.-R., Adrie, C., Garrouste-Orgeas, M., Cohen, Y., Mourvillier, B., et al. (2006) · Chest · doi:10.1378/chest.129.1.110 · Cited by 270
Interkingdom metabolic transformations captured by microbial imaging mass spectrometry
Moree, W. J., Phelan, V. V., Wu, C.-H., Bandeira, N., Cornett, D. S., Duggan, B. M., & Dorrestein, P. C. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1206855109 · Cited by 239
Mowat, E., Rajendran, R., Williams, C., McCulloch, E., Jones, B., Lang, S., & Ramage, G. (2010) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2010.02130.x · Cited by 199
Briard, B., Bomme, P., Lechner, B. E., Mislin, G. L. A., Lair, V., Prévost, M.-C., Latgé, J.-P., Haas, H., & Beauvais, A. (2015) · Scientific Reports · doi:10.1038/srep08220 · Cited by 161
Lopez-Medina, E., Fan, D., Coughlin, L. A., Ho, E. X., Lamont, I. L., Reimmann, C., Hooper, L. V., & Koh, A. Y. (2015) · PLOS Pathogens · doi:10.1371/journal.ppat.1005129 · Cited by 143
Sass, G., Nazik, H., Penner, J., Shah, H., Ansari, S. R., Clemons, K. V., Groleau, M.-C., Dietl, A.-M., Visca, P., Haas, H., et al. (2018) · Journal of Bacteriology · doi:10.1128/jb.00345-17 · Cited by 128
Grahl, N., Demers, E. G., Lindsay, A. K., Harty, C. E., Willger, S. D., Piispanen, A. E., & Hogan, D. A. (2015) · PLOS Pathogens · doi:10.1371/journal.ppat.1005133 · Cited by 111
“albicans, phenazines, have been identified [28,29].”
Ferreira, J. A. G., Penner, J. C., Moss, R. B., Haagensen, J. A. J., Clemons, K. V., Spormann, A. M., Nazik, H., Cohen, K., Banaei, N., Carolino, E., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0134692 · Cited by 92
Brand, A., Barnes, J. D., Mackenzie, K. S., Odds, F. C., & Gow, N. A. R. (2008) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2008.01301.x · Cited by 86
Purschke, F. G., Hiller, E., Trick, I., & Rupp, S. (2012) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m112.017673 · Cited by 60
“albicans and Aspergillus fumigatus (36).”
Risk factors for persistent Aspergillus respiratory isolation in cystic fibrosis.
Hong, G., Psoter, K. J., Jennings, M. T., Merlo, C. A., Boyle, M. P., Hadjiliadis, D., Kawut, S. M., & Lechtzin, N. (2018) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2018.01.008 · Cited by 59
Kaur, A. P., Lansky, I. B., & Wilks, A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m806068200 · Cited by 55
Iron acquisition in the cystic fibrosis lung and potential for novel therapeutic strategies
Tyrrell, J., & Callaghan, M. (2016) · Microbiology · doi:10.1099/mic.0.000220 · Cited by 56
Zhang, I., Pletcher, S. D., Goldberg, A. N., Barker, B. M., & Cope, E. K. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.02477 · Cited by 51
Metadata
- Authors
- Kerr, J. R., Taylor, G. W., Rutman, A., Høiby, N., Cole, P. J., & Wilson, R.
- Venue
- Journal of Clinical Pathology
- Publisher
- BMJ
- Published
- 1999-05
- Volume
- 52
- Issue
- 5
- Pages
- 385-387
- ISSN
- 0021-9746 (ISSN-L)
- 1472-4146
- OpenAlex
- W2171089401
- Cited by
- 304
- References
- 6
- FWCI
- 0.43
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.